UPSC MainsMEDICAL-SCIENCE-PAPER-I20255 Marks
हिंदी में पढ़ें
Q20.

Briefly describe the development of Cell-Mediated Immunity. List the cell types involved, along with their actions.

How to Approach

To answer this question effectively, I will begin by defining cell-mediated immunity and briefly contrasting it with humoral immunity. The body will detail the sequential development of cell-mediated immunity, emphasizing the crucial role of Antigen-Presenting Cells (APCs) and the activation of T lymphocytes. I will then systematically list and explain the specific actions of each involved cell type. The conclusion will summarize the importance of CMI in defending against intracellular pathogens and abnormal cells.

Model Answer

0 min read

Introduction

Cell-mediated immunity (CMI), also known as cellular immunity, is a crucial adaptive immune response that does not rely on antibodies. Instead, it involves the activation of phagocytes, antigen-specific cytotoxic T lymphocytes, and the release of various cytokines in response to an antigen. This arm of the immune system is primarily responsible for defending the body against intracellular pathogens like viruses and certain bacteria, fungi, and parasites, as well as detecting and eliminating cancerous cells. Unlike humoral immunity, which targets extracellular pathogens and their toxins, CMI's strength lies in its ability to directly recognize and destroy infected or abnormal cells, ensuring effective containment and eradication of internal threats.

Development of Cell-Mediated Immunity

The development of cell-mediated immunity is a complex, multi-step process initiated upon the body's encounter with an intracellular pathogen or an abnormal cell. It primarily involves T lymphocytes and antigen-presenting cells (APCs).
  1. Antigen Presentation: The process begins when an Antigen-Presenting Cell (APC), such as a dendritic cell or macrophage, engulfs a pathogen or a cancerous cell. The APC then processes the foreign antigen into smaller peptides. These antigenic peptides are loaded onto Major Histocompatibility Complex (MHC) molecules (Class I or Class II) and displayed on the APC's surface.
  2. T-cell Activation: The APC then travels to secondary lymphoid organs (like lymph nodes or spleen) where it encounters naive T lymphocytes.
    • Naive CD4+ T helper cells recognize antigens presented on MHC Class II molecules by APCs. This interaction, along with co-stimulatory signals, activates the T helper cell.
    • Naive CD8+ cytotoxic T cells recognize antigens presented on MHC Class I molecules by APCs or infected cells. Full activation often requires help from activated CD4+ T helper cells and appropriate co-stimulation.
  3. Clonal Expansion and Differentiation: Upon activation, both CD4+ T helper cells and CD8+ cytotoxic T cells undergo rapid proliferation, generating numerous effector cells specific to the encountered antigen. These effector cells then differentiate into various subsets, each with specialized functions.
  4. Effector Phase: The activated effector T cells migrate to the site of infection or tumor.
    • Cytotoxic T Lymphocytes (CTLs) directly identify and kill infected or cancerous target cells.
    • Helper T cells secrete cytokines that amplify the immune response, activating other immune cells like macrophages and B cells.
  5. Memory Formation: After the pathogen is cleared, most effector T cells die, but a subset of them survives as memory T cells. These memory cells persist in the body, providing long-lasting immunity and enabling a faster, more robust response upon subsequent exposure to the same antigen.

Cell Types Involved and Their Actions

Cell-mediated immunity is orchestrated by several key cell types, primarily T lymphocytes, with crucial support from Antigen-Presenting Cells and other innate immune cells.
Cell Type Primary Action(s) Role in CMI
Antigen-Presenting Cells (APCs)
(e.g., Dendritic Cells, Macrophages)
  • Phagocytosis of pathogens/abnormal cells.
  • Processing and presentation of antigenic peptides on MHC Class I and Class II molecules.
  • Provide co-stimulatory signals for T-cell activation.
Initiates the adaptive immune response by activating naive T cells. Dendritic cells are considered the most potent APCs.
Helper T Cells (TH cells / CD4+ T cells)
  • Recognize antigens presented on MHC Class II molecules.
  • Secrete various cytokines (e.g., IL-2, IFN-γ, TNF-α).
  • Activate cytotoxic T cells, macrophages, and B cells.
Central to coordinating and amplifying both cell-mediated and humoral immune responses. Essential for full activation of CD8+ T cells.
Cytotoxic T Lymphocytes (CTLs / CD8+ T cells)
  • Recognize antigens presented on MHC Class I molecules on infected or cancerous cells.
  • Induce apoptosis (programmed cell death) in target cells by releasing perforins and granzymes.
Directly kill cells infected with intracellular pathogens or cancerous cells, thereby eliminating the source of infection or malignancy.
Memory T Cells
(Memory CD4+ and CD8+ T cells)
  • Long-lived cells that persist after the primary infection.
  • Mount a rapid and robust immune response upon re-exposure to the same antigen.
Provide immunological memory, ensuring faster and more effective protection against recurrent infections.
Regulatory T Cells (Treg cells)
  • Suppress immune responses to maintain self-tolerance and prevent autoimmunity.
  • Secrete immunosuppressive cytokines (e.g., IL-10, TGF-β).
Crucial for modulating the intensity and duration of the immune response, preventing excessive inflammation and damage to host tissues.
Natural Killer (NK) Cells
(Innate Lymphoid Cells)
  • Recognize and kill target cells that lack MHC Class I molecules (often seen in virus-infected or tumor cells).
  • Release cytotoxic granules (perforins and granzymes).
  • Part of innate immunity but collaborate with adaptive CMI.
Provide an immediate, non-specific defense against infected and cancerous cells, complementing the specific action of CTLs.

Conclusion

Cell-mediated immunity is a sophisticated and vital component of the adaptive immune system, primarily responsible for recognizing and eliminating intracellular threats and abnormal cells. Its development involves a precise cascade of events, from antigen presentation by APCs to the activation, proliferation, and differentiation of specialized T lymphocytes. The coordinated actions of Helper T cells, Cytotoxic T lymphocytes, and other immune cells ensure the effective eradication of infected or cancerous cells and the establishment of immunological memory for future protection. Continuous research into CMI mechanisms is crucial for developing advanced immunotherapies and vaccines, especially for challenging diseases like cancer and chronic viral infections.

Answer Length

This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.

Additional Resources

Key Definitions

Cell-Mediated Immunity (CMI)
An adaptive immune response mediated by antigen-specific T lymphocytes and other immune cells, rather than by antibodies, primarily targeting intracellular pathogens and abnormal cells.
Major Histocompatibility Complex (MHC)
A set of genes that code for cell surface proteins essential for the adaptive immune system. MHC molecules display antigenic peptides to T cells, facilitating their recognition of self versus non-self.

Key Statistics

A recent study (2024-10-22) published in the International Journal of Clinical Biochemistry and Research found a 30% increase in autoimmune disorders among the Indian population since the COVID-19 pandemic, suggesting a link between viral infections and intensified immune responses that can sometimes trigger autoimmune conditions. The study by Metropolis Healthcare analyzed 1.2 lakh cases, showing ANA positivity surged from 39.3% in 2019 to 69.6% in 2022.

Source: International Journal of Clinical Biochemistry and Research / Metropolis Healthcare

The GOQii India Fit Report 2020 indicated that 20.8% of Indians suffered from low immunity levels (defined as falling ill more than three times a year), with teens and seniors being more susceptible. This highlights the general vulnerability of a significant portion of the Indian population to infections.

Source: GOQii India Fit Report 2020

Examples

HIV Infection and CMI

In HIV infection, the virus primarily targets CD4+ Helper T cells. The progressive destruction of these cells severely cripples cell-mediated immunity, making individuals highly susceptible to opportunistic infections and certain cancers, demonstrating the critical role of CD4+ T cells in coordinating immune responses.

Cancer Immunotherapy with CAR T-cells

Chimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary cancer treatment that harnesses cell-mediated immunity. A patient's T cells are genetically engineered to express a CAR that recognizes specific antigens on cancer cells. These "CAR T-cells" are then infused back into the patient, where they specifically seek out and destroy tumor cells, showcasing the therapeutic potential of engineered CMI.

Frequently Asked Questions

What is the main difference between cell-mediated immunity and humoral immunity?

The main difference is that cell-mediated immunity (CMI) is mediated by T cells and directly targets infected or abnormal cells, without producing antibodies. Humoral immunity, on the other hand, is mediated by B cells and relies on the production of antibodies to neutralize extracellular pathogens and toxins.

Can cell-mediated immunity be boosted?

Yes, cell-mediated immunity can be boosted through various means, including vaccination, which can stimulate T cell responses. Lifestyle factors such as a healthy diet, regular exercise, and adequate sleep also contribute to overall immune system strength. Immunotherapies, particularly in cancer treatment, are designed to enhance specific cell-mediated responses.

Topics Covered

ImmunologyPhysiologyImmune SystemCellular ImmunityT Lymphocytes